Structure–Activity Relationships and Biological Evaluation of 7-Substituted Harmine Analogs for Human β-Cell Proliferation
Year: 2020
Type: article
Abstract: Recently, we have shown that harmine induces β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway. We explore structure–activity relationships of the 7-position of harmine for both DYRK1A kinase inhibition and β-cell proliferation based on our related previous structure–activity relationship studies of harmine in the context of diabetes and β-cell specific targeting strategies. 33 harmine analogs of the 7-position substituent were synthesized and evaluated for biological activity. Two novel inhibitors were identified which showed DYRK1A inhibition and human β-cell proliferation capability. The DYRK1A inhibitor, compound 1-2b, induced β-cell proliferation half that of harmine at three times higher concentration. From these studies we can draw the inference that 7-position modification is limited for further harmine optimization focused on β-cell proliferation and cell-specific targeting approach for diabetes therapeutics.
Source: Molecules
Institution: Icahn School of Medicine at Mount Sinai
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,112
Awards: G3415029776, G3426021646, G464855746, Molecular Mechanisms of Physiologic Beta Cell Growth in Juvenile Human Pancreas, G5523990553, Novel Selective Type II kinase Inhibitors to treat Diabetes, G7863164370, G8034520583, G8275183597, G8671509285, NYR-Diabetes Research Center (NYR-DRC), Chemical and Structural Approaches to Study Energy Homeostasis Pathways in Cancer and Metabolic disorders
OpenAlex ID: W3019064502
